| 영문 | iron | 한글 | 철 |
|---|---|---|---|
| 설명 | 금속원소. 기호 Fe. 원자번호 26. 혈색소와 cytochrome, 기타 호흡기 계통의 효소를 구성하는 중요한 원소이다. |
||
| 영문 | iron deficiency anemia | 한글 | 철결핍빈혈 |
|---|---|---|---|
| 설명 | 적혈구의 기능은 산소를 운반하는데 있다. 적혈구 속에 산소와 결합을 하여 산소를 운반하는 혈색소라는 물질이 있다. 철은 이 혈색소의 중요한 부분을 이루는 것으로 철이 없으면 혈색소가 만들어질 수가 없다. 혈색소가 없으면 역시 적혈구도 만들어지지 않으므로 체내에 철이 부족하면 빈혈이 생긴다. 이 철결핍성 빈혈은 빈혈의 원인 중에서 가장 흔한 것이다(약 25%를 차지한다). 철저장량의 저하-결핍, 혈청철농도의 저하, 트란스페린량 상승, 트란스페린포화도의 저하, 혈색소농도 또는 헤마토크리트의 저하, 저색소성대적혈구를 특징으로 하는 빈혈로서, 생체 내에서 철이 장기에 걸쳐 결핍되며 그 때문에 혈색소 생산 감소에 의해 일어난다. 창자에서의 철흡수량 부족, 철의 수요 증대(유아기, 사춘기, 임신), 철소실과잉(출혈)에 의해 일어나며, 특히 사춘기에서 폐경기까지의 여성에게 많다. 증상으로서는 얼굴창백, 피로감, 피부창백, 손톱 변화(스푼 모양) 등을 나타낸다. 구강 영역에서는 혀의 접촉통, 발적, 건조감, 삼킴곤란을 수반하면 플러머-빈슨(Plummer-Vinson)증후군이라고 한다. 혈액 소견은 혈청철은 저하하며, 철결합능력의 상승, 저색소성 작은적혈구성을 나타낸다. |
||
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
|---|---|
| PID | 1) Pelvic Inflammatory Disease; 골반 염증성 질환 [Chap 89, HP 534-8] 2) Plasma I... |
| PIT | Plasma Iron Turnover |
| SIBC | Saturation Iron Binding Capacity |
| TIBC | Total Iron Binding Capacity |
| COS | Carbonyl sulfide |
|---|---|
| DAS | Diallyl sulfide |
| DMS | Dimethyl sulfide |
| H(2)S | Hydrogen sulfide |
| DI | Dialyzed iron |
idea
| allyl sulfide | diallyl sulfide; thioallyl ether; oil garlic; a constituent of garlic oil used in the manufacture of flavours. (05 Mar 2000) |
|---|---|
| barium sulfide | A poisonous grayish yellow powder, used as a depilatory. (05 Mar 2000) |
| crude calcium sulfide | Used externally in the treatment of acne, scabies, and ringworm. Synonym: sulfurated lime. (05 Mar 2000) |
| selenium sulfide | A mixture of crystalline selenium monosulfide and solid solutions of selenium and sulfur in an amorphous form, containing 52 to 55.5% Se; used in the treatment of seborrhoea of the scalp or dandruff; it is applied to the scalp as a suspension. (05 Mar 2000) |
| hydrogen sulfide | <chemical> Hydrogen sulfide (h2s). A flammable, poisonous gas with a characteristic odour of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. Chemical name: Hydrogen sulfide (H2S) (12 Dec 1998) |
| sulfide | A compound of sulfur in which the sulfur has a valence of -2; e.g., Na2S, HgS; also, a thioether (i.e., R-S-R', such as lanthionine). Synonym: sulfuret. (05 Mar 2000) |
| sulfide dehydrogenase | <enzyme> From bacteria Registry number: EC 1.8.2.- Synonym: flavocytochrome c, soxb protein, soxb gene product (26 Jun 1999) |
| sulfide oxidase | <enzyme> Catalyses the conversion of hydrogen sulfide to sulfur; isolated from hyphomicrobium neptunium Registry number: EC 1.8.- (26 Jun 1999) |
| sulfide quinone reductase | <enzyme> Part of the photosynthetic electron transport chain in chlorobium; reaction occurs in the dark, in the absence of oxygen Registry number: EC 1.8.5.- Synonym: plastoquinone reductase, sulfide-quinone oxidoreductase, sqr enzyme, sulfide-quinone reductase (26 Jun 1999) |
| di(2-chloroethyl)sulfide | <chemical> 1,1'-thiobis(2-chloroethane). Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung oedema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the fourth annual report on carcinogens (ntp-85-002, 1985) (merck, 11th ed). Pharmacological action: carcinogens, chemical warfare agents, dermatologic agents. Chemical name: Ethane, 1,1'-thiobis(2-chloro- (12 Dec 1998) |
| lead sulfide | The native form in which lead is chiefly found. Synonym: galena. (05 Mar 2000) |
| albuminised iron | Iron albuminate, a compound of iron oxide and albumin; rendered soluble by the presence of sodium citrate; occurs as reddish brown, lustrous granules, odourless or nearly so; used in anaemia. (05 Mar 2000) |
| anaemia, iron deficiency | Deficiency of iron results in anaemia because iron is necessary to make haemoglobin, the key molecule in red blood cells responsible for the transport of oxygen. In iron deficiency anaemia, the red cells are unusally small (microcytic) and pale (hypochromic). Characteristic features of iron deficiency anaemia in children include failure to thrive (grow) and increased infections. The treatment of iron deficiency anaemia, whether it be in children or adults, is with iron and iron-containing foods. Food sources of iron include meat, poultry, eggs, vegetables and cereals (especially those fortified with iron). According to the National Academy of Sciences, the Recommended Dietary Allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men. Anaemia characterised by low or absent iron stores, low serum iron concentration, elevated free erythrocyte porphorin, low transferrin saturation, elevated transferrin, low serum ferritin, low haemoglobin concentration or haematocrit, and hypochromic microcytic red blood cells. Symptoms may include pallor, angular stomatitis and other oral lesions, gastrointestinal complaints, retinal haemorrhages and exudates, and thinning and brittleness of the nails. Among the causes of iron-deficiency anaemia are inadequate iron intake, impaired iron absorption, increased blood loss and increased requirements such as infancy, pregnancy, and lactation. (12 Dec 1998) |
| brain iron | <radiology> Normal, Infant: NONE, Adult: globus pallidum, substantia nigra, red nucleus, dentate nucleus, Aging: (adult) and putamen, Degenerative disease, Parkinson disease: putamen, SN compacta, Huntington disease: caudate, putamen, Alzheimer disease: cerebral cortex, Hallervorden-Spatz disease, MS: thalamus, putamen, Others, AVM: malformation and rim, Bleed: rim macrophages, Haemorrhagic CVA: gyral / basal ganglia MRI: low T1 and T2 signal (12 Dec 1998) |
| peptonised iron | A compound of iron oxide and peptone, rendered soluble by the presence of sodium citrate; used in the treatment of iron deficiency anaemia. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|